QBFM
MYGN icon

QS Batterymarch Financial Management’s Myriad Genetics MYGN Stock Holding History

QS Batterymarch Financial Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$916K Hold
23,734
– – 0.02% 540
2014
Q2 		$924K Sell
23,734
-43,750
-65% -$1.63M 0.02% 545
2014
Q1 		$2.31M Sell
67,484
-2,300
-3% -$71.3K 0.05% 468
2013
Q4 		$1.47M Buy
69,784
+484
+0.7% +$12.2K 0.03% 557
2013
Q3 		$1.63M Sell
69,300
-251,700
-78% -$7.15M 0.04% 535
2013
Q2 		$8.63M Buy
+321,000
New +$9.3M 0.17% 168

Other funds holding MYGN

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

QS Batterymarch Financial Management's MYGN Position: Q3 2014 in Review

QS Batterymarch Financial Management held its Myriad Genetics (MYGN) position steady in Q3 2014 at 23,734 shares worth $916K. The position accounts for 0.02% of the portfolio, ranked #540.

QS Batterymarch Financial Management first reported a position in MYGN in Q2 2013 and has held it in 6 quarters since. The position peaked at $8.63M in Q2 2013. 275 funds tracked by Wall St. Rank hold MYGN as of Q3 2014.

  • QS Batterymarch Financial Management held 23,734 shares of Myriad Genetics worth $916K as of Q3 2014.
  • QS Batterymarch Financial Management left its Myriad Genetics share count unchanged in Q3 2014.
  • Myriad Genetics made up 0.02% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #540 holding.
  • QS Batterymarch Financial Management first reported a position in Myriad Genetics in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's Myriad Genetics position peaked at $8.63M in Q2 2013.
  • 275 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.